Cyclophosphamide therapy induces ovarian failure in premenopausal women affected by systemic lupus erythematosus.
Tincani
A
A
Servizio di Immunologia Clinica Ospedali Civili, Piazza Spedali Civili no. 1 25100 Brescia, Italy.
D000328:Adult; D003520:Cyclophosphamide / Q000009:adverse effects*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008875:Middle Aged; D017697:Premenopause; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000453:epidemiology; D012189:Retrospective Studies; D012219:Rheumatology / Q000379:methods; D012307:Risk Factors
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide